HAWAI’I TECH ASIA

1

HAWAI’I TECH ASIA

“Bringing Hawai’i Tech Companies to Asia/China”September 22-23, 2011 • Singapore

September 26-29, 2011 • Hong Kong & ShenzhenSpring 2012 • Beijing and Shanghai

PARTNERS

Please contact: Dr. Bee Leng Chua, Executive Director, HiBEAM.Tel: +1 808-722-6289 [email protected] www.hibeam.org

2

HAWAII TECH ASIA 2011 22-23 September in Singapore;26-29 September in Hong Kong and Shenzhen

HiBEAM is pleased to launch Hawaii Tech Asia (HTA) that aims to bring Hawaii and UStechnology entrepreneurs to Hong Kong and Shenzhen to gain on-the-ground China and Asiamarket exposure and to initiate connections with potential investors, distributors, suppliers,partners, and customers. Hawaii Tech Asia will introduce participating companies to theventure capital, private equity, and angel investor communities in Beijing and Hong Kong – aswell as to legal, accounting and business development professionals who can assist them innavigating the China market. Expected outcomes of the visit will be rich collaborations, jointventures, or partnerships with China and Hong Kong firms.

COMPANY SUMMARIES

Biotechnology and Medical Technology3 Cardax Pharmaceuticals

Eyegenix

4 Hawaii Biotech, Inc. Kai Medical

5 Nanopoint Imaging Inc. Lotus Innovative Health

6 Tissue Genesis, Inc.6 TruTag Technologies

7 Clean Technology - Decongel

Aquaculture - High Health Aquaculture

Digital Media, Information Technology, and Software8 Makery Technologies (Singapore Only)

Ocean Network

9 Publishing and eCommerce - Franko Maps

9 Observer – Kahala Associates

10 About Hawai’i Tech Asia12 Program Partners

13 About HiBEAM (Hawaii Business Entrepreneur Acceleration Mentors)

3

COMPANY SUMMARIES

Cardax Pharmaceuticals is developing proprietary small molecule prodrug therapies whereinflammatory pathways play an important pathological role in large unmet medical needs, inparticular dyslipidemia, arthritis, liver disease, and metabolic syndrome. Most anti-inflammatory agents have long-term side effects that limit their utility. In contrast, theCompany’s proprietary, synthetically produced, natural compound products reduceinflammatory pathways in a different, quantifiable, and inherently safer manner. In humans,the active drug of the Company’s lead product, CDX-085, lowers triglycerides and TNF-, amajor inflammatory mediator, while raising adiponectin and HDL-C,

2 important measures

relating to dyslipidemia, metabolic syndrome, osteoarthritis, RA, and liver disease.Contact:

David Watumull, CEOTel: +1-808-547-1375

Fax: (808) [email protected]

www.cardaxpharma.com

EyegenixTM has the exclusive worldwide commercial rights to a biosynthetic artificial cornealmaterial for transplantation, which holds the potential promise to cure the estimated 10 millionpeople who suffer from corneal blindness but have no access to a transplant due to a globalshortage of donors. Eyegenix is a wholly-owned subsidiary of Cellular Bioengineering Inc. CBI iscurrently making preparations for expanded trials of the bio engineered cornea and completingcertified manufacturing facilities for large scale clinical production, both for use in the next set ofclinical trials and for eventual global patient use.

Contact:Dr. Tony Lee, [email protected]

4

Hawaii Biotech, Inc. (HBI) is a privately held biotechnology company focused on the researchand development of vaccines for established and emerging infectious diseases. The companyhas developed proprietary expertise in the production of recombinant proteins applicable to thedevelopment of safe and effective vaccines. Lead vaccine candidates in clinical developmenttarget the West Nile virus and Dengue virus. Additional recombinant protein subunits vaccinecandidates produced from this protein production platform are currently under development. InAugust of 2010, Merck Sharp and Dohme purchased certain assets from including all rights tothe dengue virus vaccine developed by the Company.

Contact:Dr. Elliot Parks, CEOTel: +1-808- [email protected] www.hibiotech.com

Kai Medical, Inc. designs, manufactures and distributes novel non-contact respiratory ratemonitors, apnea therapy devices and driver fatigue detection systems. The Kai Spotrespiration monitor delivers the first Doppler radar based non-contact respiratory ratemeasurements cleared by the FDA. The Kai Spot and Kai Continuous are CE marked andavailable for sale in the EU and in most of Asia with country specific regulatory registration.The company is expanding its sales and distribution channels to include Asia and is exploringstrategic investor and distribution partnerships. The company is also seeking a strategicpartnership with a patient monitor medical device manufacturer to integrate the non-contactsensor.

Contact:Bob Nakata, CEO

Tel: +1 808.687.2900Fax: +1 808.356.0367

[email protected] www.kaimedical.com

5

Nanopoint is a privately-held imaging and microfluidics platform company that is revolutionizingbiomedical research with its novel compact inverted microscope and extended time-lapse livecell imaging solutions. Nanopoint’s cellTRAY® Mini-Microscope product is both a generalpurpose inverted laboratory microscope capable for capturing high quality images for scientificpublications and a robust teaching platform for aspiring young scientists. Nanopoint’s award-winning, patented cellTRAY®, cellTRAY® Dish, and patent-pending automated microfluidicsdelivery system, on-stage incubation system and proprietary imaging software providessolutions to a broad spectrum of applications including drug discovery, assisted reproduction,cryopreservation, stem cell research, and other clinical applications.

Contact:Cathy Owen, CEOTel: 1- 808 - [email protected]

Lotus Innovative Health (LIH), Ltd. is a privately held company specializing in the developmentand commercialization of novel therapeutics for diseases of the eye caused by angiogenesis.Our current focus is on the development of orally-delivered and topical therapeutics that caninhibit angiogenesis and treat eye diseases such as wet age-related macular degeneration(AMD) and diabetic retinopathy (DR). We have isolated and patented two separate compoundsfrom natural sources that are highly anti-angiogenic at small doses and have high potential forthe treatment of these diseases. We will also be developing and selling related nutritionalsupplements for eye health and for the prevention of eye disease..

Contact:Ming-Chung Wong, CEO

[email protected] US: 1-510-266-0515

M: 1-510-862-7895HK: 852-2381-8904

www.retinapharmainc.com

6

Tissue Genesis, an emerging leader in adipose-derived cell therapy and regenerative medicine,is a high-growth, clinical-stage company based in Honolulu, Hawai’i. Industry-leading engineersand scientists have developed a proprietary process for Tissue Genesis that promote innovativemedical solutions for a wide range of existing medical problems, including: cardiac andperipheral vascular disease: orthopedic injuries; aesthetic and soft tissue defects; and manyother applications.

Contact:Rex Chang M.D.Director of Business DevelopmentTel: +1 [email protected]

TruTag Technologies provides microscopic, edible security solutions that enable item-levelauthentication and tracking for manufacturers of pharmaceuticals, food, medical devices,electronic components, luxury goods, industrial parts and more. These covert, heat resistant,edible, 100% silica microtags can be easily added to any manufacturing process and provideanti-counterfeiting protection plus multiple other benefits. These are low cost and in addition tohelping to prevent counterfeiting, can also reduce costs related to bogus/improperlydocumented product returns, add efficiency to inventory controls, clinical trials administration,provide informatics to drive patient compliance with medical regimens, and assure productquality.

Contact:Peter Wong, [email protected]

7

DeconGel® is a proven, tough, professional, military-grade, safe to use and handle, watersoluble, and environmentally friendly product for extreme, hard-to-clean contaminationremediation challenges for any industry. It is exceptionally effective against radioactive isotopesbut has the strength to pull off any job – from radioactive isotopes for nuclear plantdecommissioning and nuclear medicine spills, to toxic industrial chemicals and materials suchas mercury, PCB, acids, lead, asbestos, and methamphetamines. DeconGel ® is effective, hasoutstanding efficacy, and can save time and money through reduced labor, waste disposalneeds and EPA reporting requirements. DeconGel® is used in the US, Canada, UK, and otherlocations to remove radioactive materials and Toxic Industrial Chemicals (TIC). DeconGel®customers are: Military Weapons and Department of Energy and Decommissioning andDecontamination (D&D) sites; Military and commercial nuclear power plants and nuclearpowered ships; Nuclear medicine and research laboratory environments using radioisotopesand hazardous chemicals and substances; and hazardous chemical clean-up in anyenvironment.

Contact:Dr. Hank Wuh, CEO, Skai VenturesPhone +1 808 949-2208 Ext. 108Email: [email protected]

High Health Aquaculture (HHA) is a Hawaii-based shrimp breeding and broodstock (parentstock) supply company. Founded in 1994, HHA was the world’s first commercial company tobreed and supply domesticated Specific Pathogen Free (SPF) shrimp to the global shrimpfarming industry. The use of SPF shrimp has revolutionized the shrimp industry in many ways.The original species of HHA’s SPF shrimp was Penaeus vannamei (Pacific White). In 2000 theworld’s production of shrimp was dominated by Penaeus monodon (Black Tiger) at about 80%of world production, as this was the dominant farmed species throughout Asia. With theadoption and success of SPF vannamei, production of vannamei is estimated at over 85% ofworld farmed shrimp production in 2010. As a direct result of this switch to domesticated SPFvannamei in Asia, world shrimp farming production tripled in total production to 3 MMT. HHAplayed a major role in this revolution and has supplied live SPF broodstock shrimp to 27countries. Over the years, HHA has developed SPF stocks of Penaeus monodon (Black Tiger)and Penaeus stylirostris (Pacific Blue) shrimp species. HHA owns the world’s most diversegenetic collection of domesticated SPF shrimp.

Contact:Jason Ueki, VP [email protected]: +1-808-557-8080Fax: +1-808-443-0231www.SPFgenetics.com

8

(Only for Singapore)

The Makery Technologies consists of a collection of hand tools and conventional machines,along with advanced design and manufacturing software that interface with a computerizedmilling machine. All of this is arranged in a compact pod-like structure. The potentialapplications are Education and Training at middle and high school, vocational and technicaltraining, polytechnics and universities; Rapid Prototyping for companies, research labs,universities, and commercial Makeries; Manufacturing for small-scale production, collaborativeor distributed manufacturing, custom and specialized products. There is potential for personalapplications whereby inventors, hobbyists, model makers can come to a center to work, basedon the “Kinko Model”. The Makery Technologies is already in operation and can be licensed tocustomers with a training package.

Contact:Dr. Neil Scott,Director, Archimedes Hawaii Project

[email protected]

Ocean Network seeks to LOCATE, ORGANIZE and DELIVER the world’s Ocean content overBroadcast and Cable TV, Internet, Internet Protocol TV and mobile platforms. Ocean Networkis available in its first of what will be numerous cable markets, in Honolulu on Oceanic TimeWarner digital Channel 349 – all hours. Our programming highlights four areas: Education,Recreation, Advocacy and Information, there will always be advocacy for the world’s oceansand all water environments. Surfing, fishing, diving, boating and all water sportscomplement programs that showcase hands-on experiences by hosts who film and documentlife over and under the oceans. Programs scheduled have been produced locally, nationallyand internationally with an eye toward variety in the areas of documentaries and vivid oceanlife, with something for the whole family to enjoy. We seek to be THE Ocean Network for theworld.

Contact:Ken SandersPresident and CEOTel: +1 [email protected]

9

FRANKO MAPS LTD: A Franko Map is a guidebook or a trip planner on one page. FrankoMaps are colorful and bright. They are printed on durable waterproof synthetic paper using faderesistant inks. The maps provide a wealth of planning and travel information about a visitordestination including scenery, historical sites, cultural facts, activities, attractions and thefavorite recommendations of what to see and do. The maps are an honest effort to provide themost pertinent travel information and “insider” recommendations to the visitor without thecompromise of advertising. The mission of Franko Maps Ltd. is to provide, continuallyimprove and broadly distribute visually appealing and informative guide maps ofinteresting destinations for the world's travelers incorporating beautifully rendered andrelevant information using only the highest production standards and materials.Backed by an E-commerce website, Franko Maps Ltd. is currently active in seven regions withover 100 map titles. Over $4MM in sales has been accomplished to date.

Contact:Peter W Cannon, CEO

Tel: +1 808 636 [email protected]

Website: FrankoMaps.com

Observer

Kahala Associates is a real estate brokerage and the first wholly agent-owned companyin Hawaii. Its focus and driving passion is to provide concierge service and financialhealth through real estate. By investing in the latest technology, Kahala Associates isable to provide a more timely and personal response to client requests. As a result,clients are more informed and connected, from following market trends, identifyingopportunities and tracking the marketing and transaction process to searching forhomes or investment property on Oahu and destinations worldwide. Kahala Associatesis a member of the largest global network, Leading Real Estate Companies of theWorld® as well as a charter member of The Luxury Portfolio Fine Property Collection®.These affiliations align Kahala Associates with the key players in national andinternational markets and offer its clients the best of both worlds ~ local marketpresence and international visibility.

Contact:Myra BrandtPrincipal Broker/OwnerTel: +1 [email protected]

10

HAWAI’I TECH ASIAA Program to Enhance the Abilities of U.S. Technology

Companies to Embark on Asia Business Expansion

September 26-29 (Hong Kong & Shenzhen), 2011

Hawaii Tech Asia (HTA), being launched as a project of HiBEAM, aims to bring Hawaii and UStechnology entrepreneurs to Hong Kong and Shenzhen to gain on-the-ground China and Asiamarket exposure and to initiate connections with potential investors, distributors, suppliers,partners, and customers.

Hawaii Tech Asia will introduce participating companies to the venture capital, private equity,and angel investor communities in Beijing and Hong Kong – as well as to legal, accounting andbusiness development professionals who can assist them in navigating the China market.Expected outcomes of the visit will be rich collaborations, joint ventures, or partnerships withChina and Hong Kong firms.

Hong Kong has long been a springboard for companies who seek markets and manufacturing inChina. With a solid infrastructure of financial and private equity institutions, professionalservices, and a pro-business government, Hong Kong bears an environment for local andforeign companies to thrive and grow in the region. Technology companies, focused on highgrowth, increasingly seek a listing on the Hong Kong Stock Exchange.

Participants embarking on the Hawaii Tech Asia program will develop a set of strategies forChina and Asia related business, inclusive of estimates of the kinds of organizations/people withwhom they want to link. They will attend a two-day workshop on developing a market-drivenstrategy for Asia/China.

Hong Kong and Shenzhen

During the first two days of the HTA in Hong Kong, participants will be briefed by local expertsabout the China market, the resources available in Hong Kong, and the process of networkingwith the right people to help participant companies deploy their strategies for China-relatedbusiness. Then, on the third day, participants will be introduced to and meet with, on a one-to-one, basis, the type of prospective investors, customers, suppliers, distributors, and partnersthey established in their plans. The introductions will be facilitated by the U.S. ForeignCommercial Services Gold Key Service, HK Trade and Development Council and HiBEAM. Onthe fourth day, companies will go to Shenzhen, China to visit and meet technology companiesand venture capital firms.

Upon return to Hawaii, participants are encouraged to follow up on their new contacts andinformation learned, and make important revisions to their Asia/China strategic plans.

The HTA seeks to align with the National Export Initiative (NEI) launched by President BarackObama on March 11, 2010. The goal of the NEI is for the United States to double its exports ofgoods and services around the world in five years. HTA is also aligned with the mission of the

11

Pacific Bridge Initiative (PBI), Established by the Hong Kong Trade Development Council(HKTDC) and the U.S. Foreign Commercial Service in Hong Kong, PBI aims to double U.S.exports to Asia and (especially) Mainland China in five years. Hawaii entrepreneurs participatingin the project will be from sectors designated as priority in the PBI. Hawaii Tech Asia supportsPresident Obama’s goal to promote innovation-based and high growth U.S. companies thathave the capacity to expand into global markets in order to create high value jobs in America.

Singapore – 22 and 23 September 2011

For participants interested in establishing ties to South East Asia, a follow-on visit to Singaporewith introductions to Singapore-based stakeholders will be offered after Hong Kong andShenzhen.

Beijing and Shanghai– Spring 2012

The Beijing program will comprise of briefings about the general conditions for exporting to anddoing business in China. Participants will have meetings with investors, distributors andpotential business partners. There will be a visit to Zhongguancun, the science and technologypark in Haidian District, Beiijing. The Hawaii State Department of Business EconomicDevelopment and Tourism (DBEDT) Office in Beijing will assist in the Beijing and Shanghaiprogram.

We invite these US technology companies to join the Hawaii Tech Asia program and begin tobuild a strategy for Asia and China and thereby enhance their competitiveness in their sectors.

• Hawaii technology companies and US tech companies with an Asia/China strategy, orwants to develop a strategy for Asia/China

• Are in markets that have rapid and high growth potential• Company holds intellectual property with respect to its products/services• Has a dedicated management team that will implement the strategy

Please contact:Bee-Leng Chua, PhDExecutive Director, HiBEAM1099 Alakea St, Suite 1800Honolulu, HI 96813, [email protected]

12

Partners and Supporters

Hawaii Tech Asia is organized by HiBEAM with its partners, Center for Entrepreneurship and theCentre for Clinical Trials of The Chinese University of Hong Kong (CUHK). Supportingorganizations include the Hong Kong Venture Capital and Private Equity Association, the HKBusiness Angel Network and the Hong Kong Science and Technology Parks. The U.S.Commercial Service in Hawaii and Hong Kong, and the Hong Kong Trade Development Council(HKTDC) will also assist in the project. The partner in Hawaii is the State of Hawaii Department ofBusiness, Economic Development and Tourism (DBEDT). Corporations and government agenciesthat share the same objective to help US tech entrepreneurs will have the opportunity to supportkey events in the program. Baker & Mckenzie in Hong Kong is the sponsor and program partnerfor the Hawaii Tech Asia Forum on September 26. John Lo of Lister Lo Lui & Choy and Dr. WiltonChau of CUHK are organizers of the Shenzhen program on Sept 29. The Hong KongBiotechnology Organization is a co-organizer.

Hawai’i Business and Entrepreneurs Acceleration Mentors (HIBEAM) is a not-for-profitorganization, created to help launch and build promising early stage Hawaii technology,biotechnology and life sciences companies (HIBEAM Portfolio Companies) by providing expertprofessional advice and access to global resources. www.hibeam.org

The Center for Entrepreneurship (CfE) of The Chinese University of Hong Kong, (CUHK) isan organization dedicated to understanding, documenting and promoting entrepreneurship in HongKong, the Pearl River Delta, Greater China and the world through research, education andpractice. www.entrepreneurship.baf.cuhk.edu.hk

The Center for Clinical Trials (CCT) of The Chinese University of Hong Kong (CUHK) is anorganization dedicated to providing quality clinical research services to industry sponsors,individual investigators and entrepreneurs who are interested in clinical drug trials and devicedevelopment and to working closely with the international, regional and local groups in themanagement of clinical trials. www.cct.cuhk.edu.hk

Supporting Individuals and OrganizationsAmerican Chamber of Commerce Hong KongExploit Technologies, A*STAR, SingaporeHigh Technology Development Corporation, HawaiiHong Kong Venture Capital AssociationHong Kong Business Angels NetworkICS Trust (Asia) LtdHong Kong Science and Technology ParksHong Kong Biotechnology OrganizationDanny Lui, Managing Director, Startup Venture Capital AsiaMichele Matsuda, President, SI Investments

HAWAI’I TECH ASIA

Documents

Transcript of HAWAI’I TECH ASIA